Homepage

De gekozen onderzoeksgroep is inmiddels offline, kijk bij de onderzoekspagina voor andere passende opties. Of bekijk alle onderzoeken

PRA-RPUBEA21-0D1NLL

Multiple Sclerose (MS)

  • M/F
  • 18 - 54 years old
  • Healthy

Clinical trial of a new compound that is being developed for the treatment of multiple sclerosis (MS)

Super, never done a study before but ICON did a great job

 

Maurice

Participant ICON

Find out if you qualify for this trial

  • You are a healthy male or female
  • You are between 18 and 54 years old
  • Your Body Mass Index (BMI) is between 18 and 32 kg/m2

Good to know about this trial

  • In part 1, the compound will be given both times after you have not eaten anything for at least 10 hours, including the night.
  • In part 2, the compound will be given once after fasting overnight and once after the consumption of a meal.
  • This order can also be inverted (fasting – meal consumption or meal consumption–fasting).

How does it work

How does it work?

Read more

Study groups

Register without obligation for the group of your preference

THE RESEARCH PHYSICIAN ABOUT THIS RESEARCH

Additional information

This trial consists of two parts (part 1 and part 2) and each of these parts is composed of two periods. You can only participate in one part of the trial and you will receive the compound twice: once per period. 

In this trial, cerebrospinal fluid will be collected in each part via a lumbar puncture. This procedure will be performed at four different moments during the trial (twice per period). A fine needle will be inserted at the space between two vertebrae in the lower back. This procedure will be performed by an experienced specialist (anesthesiologist).

Für Deutschland: Bitte beachten Sie: Die Arzneimittelstudien finden im niederländischen Groningen statt. Sie müssen Englisch oder Niederländisch sprechen, verstehen und lesen können, um an einer Studie teilnehmen zu können. 

WHO CAN PARTICIPATE?

Target group

  • You are a healthy male or female.
  • You are at least 18 and no more than 54 years old.
  • Your Body Mass Index (BMI)  is at least 18 and no more than 30 kg/m2. 
  • Both non-smokers and light smokers or occasional smokers (up to a maximum of 5 cigarettes per day) are allowed to participate in this clinical trial. Smoking is not allowed during your stay in our research facility.

Note:

  • You cannot participate in the trial if you have participated in another clinical trial in the 90 days prior to the first compound administration in this clinical trial (counting from the follow-up visit). For some trials this term will be 6 months, this will be discussed during your telephone screening. 
  • For this trial, you cannot (have) receive(d) an influenza and/or COVID-19 vaccine within 6 weeks prior to the start and during this trial.
  • To determine if you are suitable to participate in this trial, you will undergo a medical screening. Depending on availability, this can be performed in Groningen or in Utrecht. The medical screening consists of two separate visits. After the regular medical screening at ICON there will be an additional visit to perform an MRI scan.

As a female you can only participate if you are not pregnant, not breastfeeding and meet one of the following conditions:

  • You are using hormonal contraception (for example the contraceptive pill or intra-uterine device containing hormones) in combination with a condom;
  • You have passed the menopause (no periods for at least 12 months);
  • You have been sterilized or your male partner has been sterilized;
  • You are not sexually active according to your lifestyle;
  • You are only sexually active with a partner of the same sex.

As a male you can only participate if you meet one of the following conditions:

  • You are using a condom in combination with an additional contraception method used by your female partner;
  • You have been sterilized or your female partner is sterilized or has passed the menopause (no periods for at least 12 months);
  • You are not sexually active according to your lifestyle;
  • You are only sexually active with a partner of the same sex.

WHAT IS THE COMPENSATION FOR THIS RESEARCH?

Compensation

Based on the number of short visits between the two periods (depending on the group you will participate in) you will receive the following compensation:

  • 1 short visit between both periods: You will receive a gross compensation of € 6553 for participation in one of the groups.
  • 3 short visits between both periods: You will receive a gross compensation of € 6993 for participation in one of the groups.
  • 4 short visits between both periods: You will receive a gross compensation of € 7213 for participation in one of the groups.

Travel expenses will be reimbursed based on the distance traveled (€ 0.21 net per kilometer) with a minimum of € 13 and a maximum of € 176.40 (840 kilometers) per round trip, regardless of the mode of transportation.

HOW LONG DOES THIS RESEARCH TAKE

Period of stay and research

For both parts, the trial consists of 2 periods during which you will stay in the research facility in Groningen (location van Swietenlaan 6) for 5 days (4 nights ) in each period. There are 1 to 4 short visits between both periods. This is different between each group. The second period will be followed by 10 short visits. The follow-up visit will take place during your last short visit.

Note: You must be available for all dates to be able to participate in this clinical triail.

In this trial, cerebrospinal fluid is collected via a lumbar puncture. Researchers can extract important information from this fluid. A lumbar puncture is a safe procedure that is performed by an experienced specialist (anaesthesiologist). In the following video we explain how this works.

More information about a lumbar puncture

Explanation video

Frequently asked questions

You can participate in a trial a maximum of four times a year. There must be at least 30 days between two trials. Some trials have a longer waiting period.

During the trial, you may suffer from mild symptoms like headache or nausea. That may be caused by the medication. It might also be caused by needing to fast for the trial, for example. Those side effects are no fun, but fortunately are not dangerous.

Before a medication is tested on people, it has already been studied extensively in a lab. This enables us to predict well which side effects you might get and we can prepare you for them. It almost never happens that participants suffer from unexpected side effects. For example, an allergic reaction to the medication occurs on average once a year.

Your participation in a clinical trial is always voluntary. You can therefore decide to stop at any time. Sometimes you have to stop. For example because of family circumstances or if the doctor decides it is better for your health. If you stop, we will look at what portion of the compensation you are entitled to. It's only fair!

The amount of money you receive for your participation in a clinical trial is determined by the duration of the trial. The longer the trial takes, the higher the compensation. But there are also other factors that determine the amount of the compensation awarded, such as special medical procedures.

Current trials

Participate in another study?

View all clinical trials
View all clinical trials